Keros Therapeutics, Inc. (KROS)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 02:04PM EDT. Market open.
| Previous Close | 60.26 |
| Open | 61.18 |
| Bid | 57.71 x 100 |
| Ask | 58.05 x 100 |
| Day's Range | 57.32 - 61.18 |
| 52 Week Range | 27.02 - 73.00 |
| Volume | |
| Avg. Volume | 353,152 |
| Market Cap | 2.085B |
| Beta (5Y Monthly) | 1.27 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Are Investors Undervaluing Keros Therapeutics, Inc. (NASDAQ:KROS) By 37%?
Key Insights Keros Therapeutics' estimated fair value is US$93.42 based on 2 Stage Free Cash Flow to Equity Current...
- GuruFocus.com
Keros Therapeutics Inc (KROS) Reports Increased R&D Spending and Net Loss in 2023
Despite Higher Losses, KROS Advances Clinical Trials and Strengthens Cash Position
- Zacks
Keros Therapeutics, Inc. (KROS) is on the Move, Here's Why the Trend Could be Sustainable
Keros Therapeutics, Inc. (KROS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
© 2024 Yahoo. All rights reserved.